Predicting the Risk of a Second Basal Cell Carcinoma

Journal of Investigative Dermatology

Volumn 135, Issue 11, 2015, Pages 2649-2656

  Verkouteren, Joris A C ^a   Smedinga, Hilde ^a   Steyerberg, Ewout W ^a   Hofman, Albert ^a   Nijsten, Tamar ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; POPULATION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VALIDATION STUDY; AGE; CARCINOMA, BASAL CELL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; PATHOLOGY; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, BASAL CELL; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, SECOND PRIMARY; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84947024166     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.244     Document Type: Article

References (44)

1. Arits AH, Schlangen MH, Nelemans PJ et al. (2011) Trends in the incidence of basal cell carcinoma by histopathological subtype. J Eur Acad Dermatol Venereol 25:565-9
2. Armstrong BK, Kricker A (2001) The epidemiology of UV induced skin cancer. J Photochem Photobiol B 63:8-18
3. Bastiaens MT, Hoefnagel JJ, Bruijn JA et al. (1998) Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 110: 880-4
4. Casparie M, Tiebosch AT, Burger G et al. (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29:19-24
5. Corona R, Dogliotti E, D'Errico M et al. (2001) Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 137:1162-8
6. Dahabreh IJ, Kent DM (2011) Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 305:822-3
7. Epstein E (1973) Value of follow-up after treatment of basal cell carcinoma. Arch Dermatol 108:798-800
8. Evidence-based Richtlijn Basaalcelcarcinoom 2014. URL: http://www. nvdv.nl/wp-content/uploads/2014/08/Richtlijn-Basaalcelcarcinoom-2014. pdf (Accessed 29 May 2015)
9. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496-509
10. Flohil SC, Koljenovic S, de Haas ER et al. (2011) Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands. Br J Dermatol 165: 874-81
11. Flohil SC, Seubring I, van Rossum MM et al. (2013a) Trends in basal cell carcinoma incidence rates: a 37-year Dutch observational study. J Invest Dermatol 133:913-8
12. Flohil SC, van der Leest RJ, Arends LR et al. (2013b) Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer 49:2365-75
13. Flohil SC, van Tiel S, Koljenovic S et al. (2013c) Frequency of non-histologically diagnosed basal cell carcinomas in daily Dutch practice. J Eur Acad Dermatol Venereol 27:907-11
14. Freedman DM, Sigurdson A, Doody MM et al. (2003) Risk of basal cell carcinoma in relation to alcohol intake and smoking. Cancer Epidemiol Biomarkers Prev 12:1540-3
15. Gerstenblith MR, Rajaraman P, Khaykin E et al. (2012) Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study. Int J Cancer 131:E149-55
16. Glanz K, Gies P, O'Riordan DL et al. (2010) Validity of self-reported solar UVR exposure compared with objectively measured UVR exposure. Cancer Epidemiol Biomarkers Prev 19:3005-12
17. Graells J (2004) The risk and risk factors of a second non-melanoma skin cancer: a study in a Mediterranean population. J Eur Acad Dermatol Venereol 18: 142-7
18. Han W, Ming M, He YY (2011) Caffeine promotes ultraviolet B-induced apoptosis in human keratinocytes without complete DNA repair. J Biol Chem 286:22825-32
19. Heffernan TP, Kawasumi M, Blasina A et al. (2009) ATR-Chk1 pathway inhibition promotes apoptosis after UV treatment in primary human keratinocytes: potential basis for the UV protective effects of caffeine. J Invest Dermatol 129:1805-15
20. Hofman A, Darwish Murad S, van Duijn CM et al. (2013) The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 28:889-926
21. Hollestein LM, de Vries E, Aarts MJ et al. (2014) Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989. J Am Acad Dermatol 71:896-903
22. Housman TS, Feldman SR, Williford PM et al. (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 48:425-9
23. Huang MT, Xie JG, Wang ZY et al. (1997) Effects of tea, decaffeinated tea, and caffeine on UVB light-induced complete carcinogenesis in SKH-1 mice: demonstration of caffeine as a biologically important constituent of tea. Cancer Res 57:2623-9
24. Karagas MR, Stukel TA, Greenberg ER et al. (1992) Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA 267:3305-10
25. Kiiski V, de Vries E, Flohil SC et al. (2010) Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 146:848-55
26. Kricker A, Armstrong BK, English DR et al. (1995) Does intermittent sun exposure cause basal cell carcinoma? a case-control study in Western Australia. Int J Cancer 60:489-94
27. Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166:1069-80
28. Lovatt TJ, Lear JT, Bastrilles J et al. (2005) Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol 52:468-473
29. Lu YP, Lou YR, Xie JG et al. (2002) Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 99:12455-60
30. Milan T, Verkasalo PK, Kaprio J et al. (2003) Lifestyle differences in twin pairs discordant for basal cell carcinoma of the skin. Br J Dermatol 149: 115-23
31. Mirza SS, Tiemeier H, de Bruijn RF et al. (2014) Coffee consumption and incident dementia. Eur J Epidemiol 29:735-41
32. Miura K, Hughes MC, Green AC et al. (2014) Caffeine intake and risk of basal cell and squamous cell carcinomas of the skin in an 11-year prospective study. Eur J Nutr 53:511-20
33. Mudigonda T, Pearce DJ, Yentzer BA et al. (2010) The economic impact of nonmelanoma skin cancer: a review. J Natl Compr Canc Netw 8:888-96
34. R Core Team(2013) R: A Language and Environment for Statistical Computing.. R Foundation for Statistical Computing: Vienna, Austria
35. Richmond-Sinclair NM, Pandeya N, Williams GM et al. (2010) Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: a 16-year longitudinal study. Int J Cancer 127:2622-9
36. Robinson JK (1987) Risk of developing another basal cell carcinoma. A 5-year prospective study. Cancer 60:118-20
37. Scrivener Y, Grosshans E, Cribier B (2002) Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 147:41-7
38. Steyerberg EW (2009) Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. Springer Science+Business Media, LLC: NY, USA
39. Steyerberg EW, Eijkemans MJ, Harrell FE Jr et al. (2000) Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med 19:1059-79
40. Van Buuren S (2012) Flexible Imputation of Missing Data. Chapman and Hall/ CRC: Boca Raton, FL, USA, pp 342
41. Van den Brandt PA, Schouten LJ, Goldbohm RA et al. (1990) Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol 19:553-8
42. Vergouwe Y, Royston P, Moons KG et al. (2010) Development and validation of a prediction model with missing predictor data: a practical approach. J Clin Epidemiol 63:205-14
43. Weinstock MA, Lee KC, Chren MM et al. (2009) Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial. J Am Acad Dermatol 61:207-15
44. Wolbers M, Koller MT, Witteman JC et al. (2009) Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology 20:555-61